Jared Seehafer
About Jared Seehafer
Jared Seehafer is the CEO and Co-Founder of Enzyme, with over 15 years of experience in the medical device and biopharma industries, specializing in regulatory strategy, digital health, and product management.
Jared Seehafer: CEO & Co-Founder
Jared Seehafer is the CEO and co-founder of Enzyme, a company he co-founded in 2017. With over 15 years of experience in the medical device and biopharma industries, he has vast expertise in product management, digital health, and regulatory strategy. His career includes significant contributions to leading companies in these sectors, particularly in developing innovative healthcare solutions.
Jared Seehafer's Education and Certifications
Jared Seehafer holds an MS in Medical Device Engineering from the University of Southern California (USC) and a BA in Molecular Biology. He has also obtained a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society (RAPS). These qualifications underscore his deep knowledge and specialization in medical devices, regulatory processes, and healthcare product development.
Jared Seehafer's Background in Medical Devices and Biopharma
Jared Seehafer has a robust background in the medical device and biopharma industries. He has led spinal cord stimulator programs at St. Jude Neuromodulation, now Abbott, and worked on the UI/UX for the first hybrid closed-loop insulin pump at Medtronic Diabetes. His work also includes handling regulatory strategies and submissions for several combination drug-device products such as Amgen’s Neulasta Onpro and Repatha Pushtronex.
Jared Seehafer's Expertise in Regulatory Strategy and Submissions
Jared Seehafer's expertise includes regulatory strategy and submissions, digital health, regulated software development, and product management. Throughout his career, he has represented more than two dozen companies in interactions with the FDA and equivalent regulatory bodies. His proficiency in navigating regulatory environments has been instrumental in ensuring compliance and successful product launches.
Jared Seehafer's Leadership in Spinal Cord Stimulators and Insulin Pumps
Jared Seehafer has demonstrated leadership in the development of spinal cord stimulators and insulin pumps. At St. Jude Neuromodulation (now Abbott), he led spinal cord stimulator programs. At Medtronic Diabetes, he contributed to the UI/UX of the first hybrid closed-loop insulin pump, showcasing his ability to merge user-centric design with complex medical technologies.